Paris, France

Bernard Cimetiere


Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2000-2012

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Bernard Cimetiere: Innovator in Pharmaceutical Chemistry

Introduction

Bernard Cimetiere is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work primarily focuses on the development of innovative medicinal compounds and their applications in treating various health conditions.

Latest Patents

Cimetiere's latest patents include groundbreaking inventions such as chromene compounds, which are useful in preparing pharmaceutical compositions. These compounds are particularly relevant for treating conditions that require a D3 receptor antagonist. Another notable invention is the association of an antithrombotic and aspirin, which presents a new combination of these two substances and their pharmaceutical compositions.

Career Highlights

Throughout his career, Bernard Cimetiere has worked with esteemed companies such as Les Laboratoires Servier and Adir Et Compagnie. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of effective medicinal products.

Collaborations

Cimetiere has collaborated with several professionals in the field, including Gilbert Lavielle and Tony Verbeuren. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Bernard Cimetiere's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of innovative treatments in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…